COLL
Collegium Pharmaceutical, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$23.53
−0.72%Forward multiples
Based on analyst estimates
- P/E forward
- 3.34x
- P/E 2026E
- 3.23x
- P/E 2027E
- 3.57x
- P/E 2028E
- 4.15x
- P/S forward
- 0.85x
Trailing multiples
Trailing twelve months
- P/E TTM
- 15.38x
- PEG TTM
- 0.04x
- Price / book
- 2.34x
- Price / sales
- 0.90x
- Price / cash flow
- 2.21x
Enterprise value
- Enterprise value
- $1.5B
- EV / sales
- 1.80x
- EV / EBITDA
- 2.49x
- EV / EBIT
- 9.20x
- Market cap
- $729.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026